Barinthus Biotherapeutics (BRNS) Capital Expenditures Growth (1y) (2021 - 2025)
Barinthus Biotherapeutics (BRNS) Capital Expenditures Growth (1y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 227.76% |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Barinthus Biotherapeutics | 27.78 Mn | -39.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -83.33% |
| Mar 31, 2025 | -98.38% |
| Dec 31, 2024 | 105.07% |
| Sep 30, 2024 | -97.75% |
| Jun 30, 2024 | 111.03% |
| Mar 31, 2024 | -86.29% |
| Dec 31, 2023 | -1,034.98% |
| Sep 30, 2023 | 32.01% |
| Jun 30, 2023 | -377.67% |
| Mar 31, 2023 | 105.77% |
| Dec 31, 2022 | 38.21% |
| Sep 30, 2022 | 438.34% |
| Jun 30, 2022 | 264.14% |
| Mar 31, 2022 | 178.57% |
| Dec 31, 2021 | 117.44% |
| Sep 30, 2021 | 150.86% |
| Jun 30, 2021 | -125.88% |
| Mar 31, 2021 | 1,681.82% |